Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mitragyna speciosa:

Search results

Items: 1 to 20 of 281

1.

Design and synthesis of simplified speciophylline analogues and β-carbolines as active molecules against Plasmodium falciparum.

Pierrot D, Sinou V, Bun SS, Parzy D, Taudon N, Rodriguez J, Ollivier E, Bonne D.

Drug Dev Res. 2018 Nov 29. doi: 10.1002/ddr.21494. [Epub ahead of print]

PMID:
30499121
2.

Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.

Avery BA, Boddu SP, Sharma A, Furr EB, Leon F, Cutler SJ, McCurdy CR.

Planta Med. 2018 Nov 16. doi: 10.1055/a-0770-3683. [Epub ahead of print]

PMID:
30452072
3.

New opioid receptor modulators and agonists.

Kaye AD, Cornett EM, Patil SS, Gennuso SA, Colontonio MM, Latimer DR, Kaye AJ, Urman RD, Vadivelu N.

Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):125-136. doi: 10.1016/j.bpa.2018.06.009. Epub 2018 Jul 2. Review.

PMID:
30322454
4.

Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy.

Smid MC, Charles JE, Gordon AJ, Wright TE.

Obstet Gynecol. 2018 Oct;132(4):926-928. doi: 10.1097/AOG.0000000000002871.

PMID:
30204686
5.

Severity of Kratom (Mitragyna speciosa Korth.) Psychological Withdrawal Symptoms.

Singh D, Narayanan S, Müller CP, Swogger MT, Rahim AA, Leong Bin Abdullah MFI, Vicknasingam BK.

J Psychoactive Drugs. 2018 Nov-Dec;50(5):445-450. doi: 10.1080/02791072.2018.1511879. Epub 2018 Aug 28.

PMID:
30152738
6.

Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'.

Davidson L, Rawat M, Stojanovski S, Chandrasekharan P.

J Neonatal Perinatal Med. 2018 Aug 22. doi: 10.3233/NPM-1863. [Epub ahead of print]

PMID:
30149482
7.

Think Kratom Is a Safe Opioid Substitute? Think Again!: History, Evidence, and Possible Future for Mitragyna speciosa.

[No authors listed]

Clin Nurse Spec. 2018 Sep/Oct;32(5):E1-E2. doi: 10.1097/NUR.0000000000000399. No abstract available.

PMID:
30095528
8.

Think Kratom Is a Safe Opioid Substitute? Think Again!: History, Evidence, and Possible Future for Mitragyna speciosa.

O'Malley PA.

Clin Nurse Spec. 2018 Sep/Oct;32(5):227-230. doi: 10.1097/NUR.0000000000000392. No abstract available.

PMID:
30095521
9.

Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies.

Yusof SR, Mohd Uzid M, Teh EH, Hanapi NA, Mohideen M, Mohamad Arshad AS, Mordi MN, Loryan I, Hammarlund-Udenaes M.

Addict Biol. 2018 Aug 8. doi: 10.1111/adb.12661. [Epub ahead of print]

PMID:
30088322
10.

Kratom and General Anesthesia: A Case Report and Review of the Literature.

Vermaire DJ, Skaer D, Tippets W.

A A Pract. 2018 Jul 25. doi: 10.1213/XAA.0000000000000857. [Epub ahead of print]

PMID:
30052532
11.

Kratom: Is It the New Illicit Opiate on the Market?

Sethi R, Miller KA, McAllister R.

Prim Care Companion CNS Disord. 2018 Jul 12;20(4). pii: 15l01895. doi: 10.4088/PCC.15l01895. No abstract available.

12.

Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.

Hemby SE, McIntosh S, Leon F, Cutler SJ, McCurdy CR.

Addict Biol. 2018 Jun 27. doi: 10.1111/adb.12639. [Epub ahead of print]

PMID:
29949228
13.

The therapeutic potential of kratom.

Grundmann O, Brown PN, Henningfield J, Swogger M, Walsh Z.

Addiction. 2018 Oct;113(10):1951-1953. doi: 10.1111/add.14371. Epub 2018 Jul 13. No abstract available.

PMID:
29949213
14.

Herb-Induced Liver Injury With Cholestasis and Renal Injury Secondary to Short-Term Use of Kratom (Mitragyna speciosa).

Antony A, Lee TP.

Am J Ther. 2018 Jun 15. doi: 10.1097/MJT.0000000000000802. [Epub ahead of print] No abstract available.

PMID:
29927773
15.

Metabolomics data of Mitragyna speciosa leaf using LC-ESI-TOF-MS.

Veeramohan R, Azizan KA, Aizat WM, Goh HH, Mansor SM, Yusof NSM, Baharum SN, Ng CL.

Data Brief. 2018 Apr 4;18:1212-1216. doi: 10.1016/j.dib.2018.04.001. eCollection 2018 Jun.

16.

Medicinal herbs in the treatment of neuropathic pain: a review.

Forouzanfar F, Hosseinzadeh H.

Iran J Basic Med Sci. 2018 Apr;21(4):347-358. doi: 10.22038/IJBMS.2018.24026.6021. Review.

17.

Determination of Alkaloids in Mitragyna speciosa (Kratom) Raw Materials and Dietary Supplements by HPLC-UV: Single-Laboratory Validation, First Action 2017.14.

Mudge EM, Brown PN.

J AOAC Int. 2018 Jul 1;101(4):964-965. doi: 10.5740/jaoacint.18-0026. Epub 2018 Apr 20.

PMID:
29678221
18.

Assessment of gonadotropins and testosterone hormone levels in regular Mitragyna speciosa (Korth.) users.

Singh D, Murugaiyah V, Hamid SBS, Kasinather V, Chan MSA, Ho ETW, Grundmann O, Chear NJY, Mansor SM.

J Ethnopharmacol. 2018 Jul 15;221:30-36. doi: 10.1016/j.jep.2018.04.005. Epub 2018 Apr 5.

PMID:
29626673
19.

Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report.

LaBryer L, Sharma R, Chaudhari KS, Talsania M, Scofield RH.

J Investig Med High Impact Case Rep. 2018 Mar 16;6:2324709618765022. doi: 10.1177/2324709618765022. eCollection 2018 Jan-Dec.

20.

Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.

Singh D, Narayanan S, Vicknasingam BK, Prozialeck WC, Ramanathan S, Zainal H, Harun SN.

J Psychoactive Drugs. 2018 Jul-Aug;50(3):266-274. doi: 10.1080/02791072.2018.1443234. Epub 2018 Mar 20.

PMID:
29558272

Supplemental Content

Loading ...
Support Center